Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s12325-008-0118-7.pdf
Reference155 articles.
1. Gines P, Quintero E, Arroyo V, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology. 1987;7: 122–128.
2. Colle I, Durand F, Pessione F, et al. Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with terlipressin: a retrospective analysis. J Gastroenterol Hepatol. 2002;17:882–888.
3. Carbonell N, Pauwels A, Serfaty L, Fourdan O, Levy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology. 2004;40:652–659.
4. McCormick PA, O’Keefe C. Improving prognosis following a first variceal haemorrhage over four decades. Gut. 2001;49:682–685.
5. Freeman JG, Cobden I, Lishman AH, Record CO. Controlled trial of terlipressin (’Glypressin’) versus vasopressin in the early treatment of oesophageal varices. Lancet. 1982;2:66–68.
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Severe Bradycardia Associated with the Use of Terlipressin: A Case Report;Case Reports in Gastroenterology;2024-06-20
2. Efficacy and safety of terlipressin infusion during liver surgery: a protocol for systematic review and meta-analysis;BMJ Open;2024-03
3. Effectiveness and Safety Evaluation of Terlipressin in the Treatment of Dynamic Intestinal Obstruction in End-Stage Liver Disease;2024-02-19
4. Factors improving mortality in critically ill patients with liver failure – A systematic review;Physiology International;2023-09-05
5. ISCHEMIC SKIN NECROSIS DUE TO TERLIPRESSIN USE IN A PATIENT WITH HEPATORENAL SYNDROME: A CASE REPORT;Gastroenterology Nursing;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3